|
SUSAN DENTZER: What do they offer discounts on?
TRICIA NEUMAN: They primarily offer discounts on prescription medication.
Some offer discounts on other benefits like vision, and dental care.
We saw one that offered discounts on aroma therapy. But basically, it
is on prescription medication.
SUSAN DENTZER: And is there any central clearinghouse of information
about these cards, if I'm an individual and I just want to know what
the whole range is?
TRICIA
NEUMAN: Well, boy, that's the hard part. There is no central source
of information about prescription drug cards. So if you want information,
and you want to know what kind of discounts you can get, you have to
go to each discount drug card program individually, and you have to
get information from that program individually, and that could mean
going to the Web site, it could mean calling their 800 number. Sometimes
it means going to a pharmacy to find out what the cost of your drug
is with that card. But there's no place where you can go to get information
on all the different discount drug card programs to compare prices to
find out what you would pay with one card versus another.
SUSAN DENTZER: What about how whether or not these sponsors of these
cards are to tell you what your discounts are likely to be ahead of
time, before you even sign up?
TRICIA NEUMAN: Well, many of them do tell you discount information before
you sign up, although not all do. I think one thing that we've found
is that it's hard to generalize about these programs. There are as many
exceptions as there are rules. But even if you can get information about
the discount, we found that the discounts varied in terms of how they're
presented, which makes it pretty challenging for consumers.
So, for example, some cards will tell you the price that you pay for
a dose of your prescription, whatever it may be, but others, instead
of giving you the price, will tell you it's a 12 percent discount off
of the list price, or $12.37 discount, which you would then have to
compare to what you would purchase - the purchasing price offered by
another program. So sometimes the units that the discounts are presented
in vary from card to card, and that can make it very confusing for a
consumer.
SUSAN DENTZER: In general, how easy or difficult do you think it is
for consumers to find out all this information, figure out what is the
best card to enroll in, and actually purchase their drugs that way?
TRICIA
NEUMAN: Well, I think it takes a lot of work for a consumer to figure
out what they would pay and how they could save money with various discount
drug card programs. There really is a burden on the consumer to be a
good shopper, to go to the Internet, to go to the pharmacy sometimes,
there's a lot of work that's involved in being a well prepared consumer.
And while the savings may make the work quite worthwhile in the end,
it is quite a bit of work, and if you think about the elderly population
and the people who are out there looking for savings on their prescriptions,
it is a - we are required - they are being required to do an awful lot
of leg work in order to find out what savings they can get.
SUSAN DENTZER: Are these card programs regulated?
TRICIA NEUMAN: No, they are not considered health insurance or insurance
products, so they are virtually unregulated today. There are a few states
that have started to clamp down on discount drug card sponsors because
they have had concerns about marketing problems. Arkansas is an example
of such a state.
|
|
|
SUSAN DENTZER: In terms of cards coming down stream in the future,
we know that there is one in particular now being put together called
Together Rx. Let's talk about that, let's talk about what you think
is the future. Are these card programs going to proliferate in the future?
TRICIA NEUMAN: We have seen a number of cards sponsored by the pharmaceutical
manufacturers themselves come onto the market. Together Rx is the most
recent card to emerge, and that is sponsored by seven different pharmaceutical
companies. This may well be the wave of the future, at least in the
foreseeable future, while the Medicare debate is being more broadly
negotiated or discussed.
These programs can offer discounts on the drugs that are offered by
the pharmaceutical companies that are sponsoring the card itself. So
what that means for a senior is that if they happen to take prescriptions
that are covered by that card and made by those pharmaceutical companies,
they may be able to get savings from a particular card, but as long
as they have prescriptions from a variety of different drug manufacturers,
they may need a card from Together Rx, but they might need a Pfizer
card, or a Merck card, or a card from another company.
SUSAN DENTZER: What's in it for the big pharmaceutical manufacturers
to offer these cards?
TRICIA NEUMAN: Well, I think it is a genuine attempt to help low income
seniors in particular who have trouble with their drug expenses, and
I maybe perceive this as an interim strategy before a Medicare debate,
before a Medicare benefit is fully kicked in.
SUSAN DENTZER: Let's talk about the cards that some of the major drug
manufacturers have introduced. Are those radically different from what's
already out there?
TRICIA NEUMAN: Well, they are different in a couple of ways. The private
discount drug cards that are not offered by the pharmaceutical companies
tend to be offered to people without regard to age or income. So it's
for seniors, it's for young people, and they can be at any income group
to benefit from them. Also, the private cards that are not sponsored
by drug companies include drugs from a variety of different manufacturers.
So by contrast, the cards that are being sponsored by the pharmaceutical
industry tend to offer drugs - exclusively offer drugs that they themselves
produce, and they also tend to be limited to seniors with low incomes.
SUSAN DENTZER: And in the case of Together Rx -
TRICIA NEUMAN: Together Rx is an example of a card that is limited to
people with low incomes, but they do go up to, I think, three times
the poverty level, so it's not - it also reaches people and helps people
with moderate incomes.
SUSAN DENTZER: What's in it for these manufacturers to offer these cards?
TRICIA NEUMAN: These cards do - for the manufacturers, these cards are
a way of helping low income and moderate income seniors with their drug
expenses in an interim, in the interim, while -
These cards are a way for the manufacturers to assist low and moderate
income seniors as a Medicare debate or Medicare benefit expansion is
being considered by Congress.
SUSAN DENTZER: So it's a way of kind of -
TRICIA NEUMAN: It's a short term - it's a -
It's a way of helping. It's obviously not the same as a Medicare drug
benefit, but it is a way to help low income seniors. It's an interim
solution.
|
|
|
SUSAN DENTZER: Now, into all of this has come the proposal from Medicare
to endorse its own version of prescription drug cards. It may be one,
it may be a number depending on who decides to play in this arena. What
is it that Medicare is proposing to do?
TRICIA
NEUMAN: Medicare is proposing to allow private firms to offer discount
drug cards that would be Medicare endorsed. So this means that a private
company today that is offering a discount drug card could do the same,
but this time it could say it would be a Medicare endorsed card, and
they could market with the Medicare name.
The hope is that by marketing with the Medicare name, more people would
be attracted to their product, and with more people they would be able
to negotiate lower discounts to bring down costs even further for seniors.
SUSAN DENTZER: What are your concerns about a Medicare endorsed discount
card or setup cards?
TRICIA NEUMAN: Well, I think the advantage of a card like this is that
it could produce a lower cost for seniors. But a possible concern is
that if a senior has a card that says Medicare on it, that they might
have the hope that they actually have a Medicare drug benefit. When
they have their Medicare card today, they know Medicare pays, say, 80
percent of their doctor bills. But with a Medicare discount drug card,
they may get a discount, and that discount might be 10, 20, 30 percent
even, but it's not the same as an insurance card that would pay 80 percent
of their costs. And I think there is a real risk that seniors could
be confused by the benefits of the card.
SUSAN DENTZER: What about concerns from a larger standpoint, that it's
somehow for people who want to see an expansion of Medicare to cover
prescription drugs. Is this the kind of thing that might delay the process
- the policy process moving forward as people say well, people have
something now that's helping them out, there's no reason to rush into
a Medicare expansion?
TRICIA NEUMAN: Well, I think most people would agree that this is really
not a substitute for a Medicare drug benefit, and even if this program
is put into place in the near future, it may offer real help for seniors.
It may produce savings of 15-20 percent, and it may save hundreds of
dollars. But I think the demand for a Medicare drug benefit will still
be very real, and that seniors will continue to press for real insurance
like workers have today because they will still face high costs for
their prescriptions, even with the discount card.
|
|